Singapore, August 01, 2020: (ACN Newswire) - Made-in-Singapore cancer drug, ETC-159, has achieved a new developmental milestone in achieving "First…
Novel payloads that target tumour-initiating cells on third generation ADCs could come to market in the next couple of years…